カテゴリ： GlobalInfoResearch, 世界, 部品/材料

世界の医薬品用活性炭市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Activated Carbon for Pharmaceuticals Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO1755）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO1755
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：化学＆材料
■ ページ数：96
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の医薬品用活性炭市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

医薬品用活性炭市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の医薬品用活性炭の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

医薬品用活性炭市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・石炭系活性炭、木質系活性炭、ヤシ系活性炭

用途別セグメントは次のように区分されます。
・原薬製造、完成品製造

世界の医薬品用活性炭市場の主要な市場プレーヤーは以下のとおりです。
・Kuraray、Jacobi Carbons、Fujian Yuanli Active Carbon、Cabot Norit、Ingevity Corporation、Haycarb、Datong Coal Jinding Activated Carbon、China Energy Investment Corporation、ADA-ES

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、医薬品用活性炭製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な医薬品用活性炭メーカーの企業概要、2019年～2022年までの医薬品用活性炭の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な医薬品用活性炭メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別医薬品用活性炭の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの医薬品用活性炭の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での医薬品用活性炭市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および医薬品用活性炭の産業チェーンを掲載しています。
・第13、14、15章では、医薬品用活性炭の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 医薬品用活性炭の概要
- 種類別分析（2017年vs2021年vs2028年）：石炭系活性炭、木質系活性炭、ヤシ系活性炭
- 用途別分析（2017年vs2021年vs2028年）：原薬製造、完成品製造
- 世界の医薬品用活性炭市場規模・予測
- 世界の医薬品用活性炭生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Kuraray、Jacobi Carbons、Fujian Yuanli Active Carbon、Cabot Norit、Ingevity Corporation、Haycarb、Datong Coal Jinding Activated Carbon、China Energy Investment Corporation、ADA-ES
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：石炭系活性炭、木質系活性炭、ヤシ系活性炭
・用途別分析2017年-2028年：原薬製造、完成品製造
・医薬品用活性炭の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・医薬品用活性炭のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・医薬品用活性炭のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・医薬品用活性炭の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・医薬品用活性炭の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Activated Carbon for Pharmaceuticals market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Activated Carbon for Pharmaceuticals market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. API Production accounting for % of the Activated Carbon for Pharmaceuticals global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Coal-Based Activated Carbon segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Activated Carbon for Pharmaceuticals include Kuraray, Jacobi Carbons, Fujian Yuanli Active Carbon, Cabot Norit, and Ingevity Corporation, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Activated Carbon for Pharmaceuticals market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Coal-Based Activated Carbon
Wood-Based Activated Carbon
Coconut-Based Activated Carbon
Market segment by Application can be divided into
API Production
Finished Drug Production
The key market players for global Activated Carbon for Pharmaceuticals market are listed below:
Kuraray
Jacobi Carbons
Fujian Yuanli Active Carbon
Cabot Norit
Ingevity Corporation
Haycarb
Datong Coal Jinding Activated Carbon
China Energy Investment Corporation
ADA-ES
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Activated Carbon for Pharmaceuticals product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Activated Carbon for Pharmaceuticals, with price, sales, revenue and global market share of Activated Carbon for Pharmaceuticals from 2019 to 2022.
Chapter 3, the Activated Carbon for Pharmaceuticals competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Activated Carbon for Pharmaceuticals breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Activated Carbon for Pharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Activated Carbon for Pharmaceuticals.
Chapter 13, 14, and 15, to describe Activated Carbon for Pharmaceuticals sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Activated Carbon for Pharmaceuticals Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Activated Carbon for Pharmaceuticals Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Coal-Based Activated Carbon
1.2.3 Wood-Based Activated Carbon
1.2.4 Coconut-Based Activated Carbon
1.3 Market Analysis by Application
1.3.1 Overview: Global Activated Carbon for Pharmaceuticals Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 API Production
1.3.3 Finished Drug Production
1.4 Global Activated Carbon for Pharmaceuticals Market Size & Forecast
1.4.1 Global Activated Carbon for Pharmaceuticals Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Activated Carbon for Pharmaceuticals Sales in Volume (2017-2028)
1.4.3 Global Activated Carbon for Pharmaceuticals Price (2017-2028)
1.5 Global Activated Carbon for Pharmaceuticals Production Capacity Analysis
1.5.1 Global Activated Carbon for Pharmaceuticals Total Production Capacity (2017-2028)
1.5.2 Global Activated Carbon for Pharmaceuticals Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Activated Carbon for Pharmaceuticals Market Drivers
1.6.2 Activated Carbon for Pharmaceuticals Market Restraints
1.6.3 Activated Carbon for Pharmaceuticals Trends Analysis
2 Manufacturers Profiles
2.1 Kuraray
2.1.1 Kuraray Details
2.1.2 Kuraray Major Business
2.1.3 Kuraray Activated Carbon for Pharmaceuticals Product and Services
2.1.4 Kuraray Activated Carbon for Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Jacobi Carbons
2.2.1 Jacobi Carbons Details
2.2.2 Jacobi Carbons Major Business
2.2.3 Jacobi Carbons Activated Carbon for Pharmaceuticals Product and Services
2.2.4 Jacobi Carbons Activated Carbon for Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Fujian Yuanli Active Carbon
2.3.1 Fujian Yuanli Active Carbon Details
2.3.2 Fujian Yuanli Active Carbon Major Business
2.3.3 Fujian Yuanli Active Carbon Activated Carbon for Pharmaceuticals Product and Services
2.3.4 Fujian Yuanli Active Carbon Activated Carbon for Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Cabot Norit
2.4.1 Cabot Norit Details
2.4.2 Cabot Norit Major Business
2.4.3 Cabot Norit Activated Carbon for Pharmaceuticals Product and Services
2.4.4 Cabot Norit Activated Carbon for Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Ingevity Corporation
2.5.1 Ingevity Corporation Details
2.5.2 Ingevity Corporation Major Business
2.5.3 Ingevity Corporation Activated Carbon for Pharmaceuticals Product and Services
2.5.4 Ingevity Corporation Activated Carbon for Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Haycarb
2.6.1 Haycarb Details
2.6.2 Haycarb Major Business
2.6.3 Haycarb Activated Carbon for Pharmaceuticals Product and Services
2.6.4 Haycarb Activated Carbon for Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Datong Coal Jinding Activated Carbon
2.7.1 Datong Coal Jinding Activated Carbon Details
2.7.2 Datong Coal Jinding Activated Carbon Major Business
2.7.3 Datong Coal Jinding Activated Carbon Activated Carbon for Pharmaceuticals Product and Services
2.7.4 Datong Coal Jinding Activated Carbon Activated Carbon for Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 China Energy Investment Corporation
2.8.1 China Energy Investment Corporation Details
2.8.2 China Energy Investment Corporation Major Business
2.8.3 China Energy Investment Corporation Activated Carbon for Pharmaceuticals Product and Services
2.8.4 China Energy Investment Corporation Activated Carbon for Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 ADA-ES
2.9.1 ADA-ES Details
2.9.2 ADA-ES Major Business
2.9.3 ADA-ES Activated Carbon for Pharmaceuticals Product and Services
2.9.4 ADA-ES Activated Carbon for Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Activated Carbon for Pharmaceuticals Breakdown Data by Manufacturer
3.1 Global Activated Carbon for Pharmaceuticals Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Activated Carbon for Pharmaceuticals Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Activated Carbon for Pharmaceuticals
3.4 Market Concentration Rate
3.4.1 Top 3 Activated Carbon for Pharmaceuticals Manufacturer Market Share in 2021
3.4.2 Top 6 Activated Carbon for Pharmaceuticals Manufacturer Market Share in 2021
3.5 Global Activated Carbon for Pharmaceuticals Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Activated Carbon for Pharmaceuticals Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Activated Carbon for Pharmaceuticals Market Size by Region
4.1.1 Global Activated Carbon for Pharmaceuticals Sales in Volume by Region (2017-2028)
4.1.2 Global Activated Carbon for Pharmaceuticals Revenue by Region (2017-2028)
4.2 North America Activated Carbon for Pharmaceuticals Revenue (2017-2028)
4.3 Europe Activated Carbon for Pharmaceuticals Revenue (2017-2028)
4.4 Asia-Pacific Activated Carbon for Pharmaceuticals Revenue (2017-2028)
4.5 South America Activated Carbon for Pharmaceuticals Revenue (2017-2028)
4.6 Middle East and Africa Activated Carbon for Pharmaceuticals Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Activated Carbon for Pharmaceuticals Sales in Volume by Type (2017-2028)
5.2 Global Activated Carbon for Pharmaceuticals Revenue by Type (2017-2028)
5.3 Global Activated Carbon for Pharmaceuticals Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Activated Carbon for Pharmaceuticals Sales in Volume by Application (2017-2028)
6.2 Global Activated Carbon for Pharmaceuticals Revenue by Application (2017-2028)
6.3 Global Activated Carbon for Pharmaceuticals Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Activated Carbon for Pharmaceuticals Sales by Type (2017-2028)
7.2 North America Activated Carbon for Pharmaceuticals Sales by Application (2017-2028)
7.3 North America Activated Carbon for Pharmaceuticals Market Size by Country
7.3.1 North America Activated Carbon for Pharmaceuticals Sales in Volume by Country (2017-2028)
7.3.2 North America Activated Carbon for Pharmaceuticals Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Activated Carbon for Pharmaceuticals Sales by Type (2017-2028)
8.2 Europe Activated Carbon for Pharmaceuticals Sales by Application (2017-2028)
8.3 Europe Activated Carbon for Pharmaceuticals Market Size by Country
8.3.1 Europe Activated Carbon for Pharmaceuticals Sales in Volume by Country (2017-2028)
8.3.2 Europe Activated Carbon for Pharmaceuticals Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Activated Carbon for Pharmaceuticals Sales by Type (2017-2028)
9.2 Asia-Pacific Activated Carbon for Pharmaceuticals Sales by Application (2017-2028)
9.3 Asia-Pacific Activated Carbon for Pharmaceuticals Market Size by Region
9.3.1 Asia-Pacific Activated Carbon for Pharmaceuticals Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Activated Carbon for Pharmaceuticals Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Activated Carbon for Pharmaceuticals Sales by Type (2017-2028)
10.2 South America Activated Carbon for Pharmaceuticals Sales by Application (2017-2028)
10.3 South America Activated Carbon for Pharmaceuticals Market Size by Country
10.3.1 South America Activated Carbon for Pharmaceuticals Sales in Volume by Country (2017-2028)
10.3.2 South America Activated Carbon for Pharmaceuticals Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Activated Carbon for Pharmaceuticals Sales by Type (2017-2028)
11.2 Middle East & Africa Activated Carbon for Pharmaceuticals Sales by Application (2017-2028)
11.3 Middle East & Africa Activated Carbon for Pharmaceuticals Market Size by Country
11.3.1 Middle East & Africa Activated Carbon for Pharmaceuticals Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Activated Carbon for Pharmaceuticals Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Activated Carbon for Pharmaceuticals and Key Manufacturers
12.2 Manufacturing Costs Percentage of Activated Carbon for Pharmaceuticals
12.3 Activated Carbon for Pharmaceuticals Production Process
12.4 Activated Carbon for Pharmaceuticals Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Activated Carbon for Pharmaceuticals Typical Distributors
13.3 Activated Carbon for Pharmaceuticals Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Activated Carbon for Pharmaceuticals Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Activated Carbon for Pharmaceuticals Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Kuraray Basic Information, Manufacturing Base and Competitors
Table 4. Kuraray Major Business
Table 5. Kuraray Activated Carbon for Pharmaceuticals Product and Services
Table 6. Kuraray Activated Carbon for Pharmaceuticals Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Jacobi Carbons Basic Information, Manufacturing Base and Competitors
Table 8. Jacobi Carbons Major Business
Table 9. Jacobi Carbons Activated Carbon for Pharmaceuticals Product and Services
Table 10. Jacobi Carbons Activated Carbon for Pharmaceuticals Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Fujian Yuanli Active Carbon Basic Information, Manufacturing Base and Competitors
Table 12. Fujian Yuanli Active Carbon Major Business
Table 13. Fujian Yuanli Active Carbon Activated Carbon for Pharmaceuticals Product and Services
Table 14. Fujian Yuanli Active Carbon Activated Carbon for Pharmaceuticals Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Cabot Norit Basic Information, Manufacturing Base and Competitors
Table 16. Cabot Norit Major Business
Table 17. Cabot Norit Activated Carbon for Pharmaceuticals Product and Services
Table 18. Cabot Norit Activated Carbon for Pharmaceuticals Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Ingevity Corporation Basic Information, Manufacturing Base and Competitors
Table 20. Ingevity Corporation Major Business
Table 21. Ingevity Corporation Activated Carbon for Pharmaceuticals Product and Services
Table 22. Ingevity Corporation Activated Carbon for Pharmaceuticals Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Haycarb Basic Information, Manufacturing Base and Competitors
Table 24. Haycarb Major Business
Table 25. Haycarb Activated Carbon for Pharmaceuticals Product and Services
Table 26. Haycarb Activated Carbon for Pharmaceuticals Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Datong Coal Jinding Activated Carbon Basic Information, Manufacturing Base and Competitors
Table 28. Datong Coal Jinding Activated Carbon Major Business
Table 29. Datong Coal Jinding Activated Carbon Activated Carbon for Pharmaceuticals Product and Services
Table 30. Datong Coal Jinding Activated Carbon Activated Carbon for Pharmaceuticals Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. China Energy Investment Corporation Basic Information, Manufacturing Base and Competitors
Table 32. China Energy Investment Corporation Major Business
Table 33. China Energy Investment Corporation Activated Carbon for Pharmaceuticals Product and Services
Table 34. China Energy Investment Corporation Activated Carbon for Pharmaceuticals Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. ADA-ES Basic Information, Manufacturing Base and Competitors
Table 36. ADA-ES Major Business
Table 37. ADA-ES Activated Carbon for Pharmaceuticals Product and Services
Table 38. ADA-ES Activated Carbon for Pharmaceuticals Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Activated Carbon for Pharmaceuticals Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Kiloton)
Table 40. Global Activated Carbon for Pharmaceuticals Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Activated Carbon for Pharmaceuticals, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Activated Carbon for Pharmaceuticals Production Capacity by Company, (Kiloton): 2020 VS 2021
Table 43. Head Office and Activated Carbon for Pharmaceuticals Production Site of Key Manufacturer
Table 44. Activated Carbon for Pharmaceuticals New Entrant and Capacity Expansion Plans
Table 45. Activated Carbon for Pharmaceuticals Mergers & Acquisitions in the Past Five Years
Table 46. Global Activated Carbon for Pharmaceuticals Sales by Region (2017-2022) & (Kiloton)
Table 47. Global Activated Carbon for Pharmaceuticals Sales by Region (2023-2028) & (Kiloton)
Table 48. Global Activated Carbon for Pharmaceuticals Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Activated Carbon for Pharmaceuticals Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Activated Carbon for Pharmaceuticals Sales by Type (2017-2022) & (Kiloton)
Table 51. Global Activated Carbon for Pharmaceuticals Sales by Type (2023-2028) & (Kiloton)
Table 52. Global Activated Carbon for Pharmaceuticals Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Activated Carbon for Pharmaceuticals Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Activated Carbon for Pharmaceuticals Price by Type (2017-2022) & (US$/Ton)
Table 55. Global Activated Carbon for Pharmaceuticals Price by Type (2023-2028) & (US$/Ton)
Table 56. Global Activated Carbon for Pharmaceuticals Sales by Application (2017-2022) & (Kiloton)
Table 57. Global Activated Carbon for Pharmaceuticals Sales by Application (2023-2028) & (Kiloton)
Table 58. Global Activated Carbon for Pharmaceuticals Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Activated Carbon for Pharmaceuticals Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Activated Carbon for Pharmaceuticals Price by Application (2017-2022) & (US$/Ton)
Table 61. Global Activated Carbon for Pharmaceuticals Price by Application (2023-2028) & (US$/Ton)
Table 62. North America Activated Carbon for Pharmaceuticals Sales by Country (2017-2022) & (Kiloton)
Table 63. North America Activated Carbon for Pharmaceuticals Sales by Country (2023-2028) & (Kiloton)
Table 64. North America Activated Carbon for Pharmaceuticals Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Activated Carbon for Pharmaceuticals Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Activated Carbon for Pharmaceuticals Sales by Type (2017-2022) & (Kiloton)
Table 67. North America Activated Carbon for Pharmaceuticals Sales by Type (2023-2028) & (Kiloton)
Table 68. North America Activated Carbon for Pharmaceuticals Sales by Application (2017-2022) & (Kiloton)
Table 69. North America Activated Carbon for Pharmaceuticals Sales by Application (2023-2028) & (Kiloton)
Table 70. Europe Activated Carbon for Pharmaceuticals Sales by Country (2017-2022) & (Kiloton)
Table 71. Europe Activated Carbon for Pharmaceuticals Sales by Country (2023-2028) & (Kiloton)
Table 72. Europe Activated Carbon for Pharmaceuticals Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Activated Carbon for Pharmaceuticals Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Activated Carbon for Pharmaceuticals Sales by Type (2017-2022) & (Kiloton)
Table 75. Europe Activated Carbon for Pharmaceuticals Sales by Type (2023-2028) & (Kiloton)
Table 76. Europe Activated Carbon for Pharmaceuticals Sales by Application (2017-2022) & (Kiloton)
Table 77. Europe Activated Carbon for Pharmaceuticals Sales by Application (2023-2028) & (Kiloton)
Table 78. Asia-Pacific Activated Carbon for Pharmaceuticals Sales by Region (2017-2022) & (Kiloton)
Table 79. Asia-Pacific Activated Carbon for Pharmaceuticals Sales by Region (2023-2028) & (Kiloton)
Table 80. Asia-Pacific Activated Carbon for Pharmaceuticals Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Activated Carbon for Pharmaceuticals Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Activated Carbon for Pharmaceuticals Sales by Type (2017-2022) & (Kiloton)
Table 83. Asia-Pacific Activated Carbon for Pharmaceuticals Sales by Type (2023-2028) & (Kiloton)
Table 84. Asia-Pacific Activated Carbon for Pharmaceuticals Sales by Application (2017-2022) & (Kiloton)
Table 85. Asia-Pacific Activated Carbon for Pharmaceuticals Sales by Application (2023-2028) & (Kiloton)
Table 86. South America Activated Carbon for Pharmaceuticals Sales by Country (2017-2022) & (Kiloton)
Table 87. South America Activated Carbon for Pharmaceuticals Sales by Country (2023-2028) & (Kiloton)
Table 88. South America Activated Carbon for Pharmaceuticals Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Activated Carbon for Pharmaceuticals Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Activated Carbon for Pharmaceuticals Sales by Type (2017-2022) & (Kiloton)
Table 91. South America Activated Carbon for Pharmaceuticals Sales by Type (2023-2028) & (Kiloton)
Table 92. South America Activated Carbon for Pharmaceuticals Sales by Application (2017-2022) & (Kiloton)
Table 93. South America Activated Carbon for Pharmaceuticals Sales by Application (2023-2028) & (Kiloton)
Table 94. Middle East & Africa Activated Carbon for Pharmaceuticals Sales by Region (2017-2022) & (Kiloton)
Table 95. Middle East & Africa Activated Carbon for Pharmaceuticals Sales by Region (2023-2028) & (Kiloton)
Table 96. Middle East & Africa Activated Carbon for Pharmaceuticals Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Activated Carbon for Pharmaceuticals Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Activated Carbon for Pharmaceuticals Sales by Type (2017-2022) & (Kiloton)
Table 99. Middle East & Africa Activated Carbon for Pharmaceuticals Sales by Type (2023-2028) & (Kiloton)
Table 100. Middle East & Africa Activated Carbon for Pharmaceuticals Sales by Application (2017-2022) & (Kiloton)
Table 101. Middle East & Africa Activated Carbon for Pharmaceuticals Sales by Application (2023-2028) & (Kiloton)
Table 102. Activated Carbon for Pharmaceuticals Raw Material
Table 103. Key Manufacturers of Activated Carbon for Pharmaceuticals Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Activated Carbon for Pharmaceuticals Typical Distributors
Table 107. Activated Carbon for Pharmaceuticals Typical Customers
List of Figures
Figure 1. Activated Carbon for Pharmaceuticals Picture
Figure 2. Global Activated Carbon for Pharmaceuticals Revenue Market Share by Type in 2021
Figure 3. Coal-Based Activated Carbon
Figure 4. Wood-Based Activated Carbon
Figure 5. Coconut-Based Activated Carbon
Figure 6. Global Activated Carbon for Pharmaceuticals Revenue Market Share by Application in 2021
Figure 7. API Production
Figure 8. Finished Drug Production
Figure 9. Global Activated Carbon for Pharmaceuticals Revenue, (USD Million) & (Kiloton): 2017 & 2021 & 2028
Figure 10. Global Activated Carbon for Pharmaceuticals Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Activated Carbon for Pharmaceuticals Sales (2017-2028) & (Kiloton)
Figure 12. Global Activated Carbon for Pharmaceuticals Price (2017-2028) & (US$/Ton)
Figure 13. Global Activated Carbon for Pharmaceuticals Production Capacity (2017-2028) & (Kiloton)
Figure 14. Global Activated Carbon for Pharmaceuticals Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Activated Carbon for Pharmaceuticals Market Drivers
Figure 16. Activated Carbon for Pharmaceuticals Market Restraints
Figure 17. Activated Carbon for Pharmaceuticals Market Trends
Figure 18. Global Activated Carbon for Pharmaceuticals Sales Market Share by Manufacturer in 2021
Figure 19. Global Activated Carbon for Pharmaceuticals Revenue Market Share by Manufacturer in 2021
Figure 20. Activated Carbon for Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Activated Carbon for Pharmaceuticals Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Activated Carbon for Pharmaceuticals Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Activated Carbon for Pharmaceuticals Sales Market Share by Region (2017-2028)
Figure 24. Global Activated Carbon for Pharmaceuticals Revenue Market Share by Region (2017-2028)
Figure 25. North America Activated Carbon for Pharmaceuticals Revenue (2017-2028) & (USD Million)
Figure 26. Europe Activated Carbon for Pharmaceuticals Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Activated Carbon for Pharmaceuticals Revenue (2017-2028) & (USD Million)
Figure 28. South America Activated Carbon for Pharmaceuticals Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Activated Carbon for Pharmaceuticals Revenue (2017-2028) & (USD Million)
Figure 30. Global Activated Carbon for Pharmaceuticals Sales Market Share by Type (2017-2028)
Figure 31. Global Activated Carbon for Pharmaceuticals Revenue Market Share by Type (2017-2028)
Figure 32. Global Activated Carbon for Pharmaceuticals Price by Type (2017-2028) & (US$/Ton)
Figure 33. Global Activated Carbon for Pharmaceuticals Sales Market Share by Application (2017-2028)
Figure 34. Global Activated Carbon for Pharmaceuticals Revenue Market Share by Application (2017-2028)
Figure 35. Global Activated Carbon for Pharmaceuticals Price by Application (2017-2028) & (US$/Ton)
Figure 36. North America Activated Carbon for Pharmaceuticals Sales Market Share by Type (2017-2028)
Figure 37. North America Activated Carbon for Pharmaceuticals Sales Market Share by Application (2017-2028)
Figure 38. North America Activated Carbon for Pharmaceuticals Sales Market Share by Country (2017-2028)
Figure 39. North America Activated Carbon for Pharmaceuticals Revenue Market Share by Country (2017-2028)
Figure 40. United States Activated Carbon for Pharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Activated Carbon for Pharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Activated Carbon for Pharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Activated Carbon for Pharmaceuticals Sales Market Share by Type (2017-2028)
Figure 44. Europe Activated Carbon for Pharmaceuticals Sales Market Share by Application (2017-2028)
Figure 45. Europe Activated Carbon for Pharmaceuticals Sales Market Share by Country (2017-2028)
Figure 46. Europe Activated Carbon for Pharmaceuticals Revenue Market Share by Country (2017-2028)
Figure 47. Germany Activated Carbon for Pharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Activated Carbon for Pharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Activated Carbon for Pharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Activated Carbon for Pharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Activated Carbon for Pharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Activated Carbon for Pharmaceuticals Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Activated Carbon for Pharmaceuticals Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Activated Carbon for Pharmaceuticals Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Activated Carbon for Pharmaceuticals Revenue Market Share by Region (2017-2028)
Figure 56. China Activated Carbon for Pharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Activated Carbon for Pharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Activated Carbon for Pharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Activated Carbon for Pharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Activated Carbon for Pharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Activated Carbon for Pharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Activated Carbon for Pharmaceuticals Sales Market Share by Type (2017-2028)
Figure 63. South America Activated Carbon for Pharmaceuticals Sales Market Share by Application (2017-2028)
Figure 64. South America Activated Carbon for Pharmaceuticals Sales Market Share by Country (2017-2028)
Figure 65. South America Activated Carbon for Pharmaceuticals Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Activated Carbon for Pharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Activated Carbon for Pharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Activated Carbon for Pharmaceuticals Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Activated Carbon for Pharmaceuticals Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Activated Carbon for Pharmaceuticals Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Activated Carbon for Pharmaceuticals Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Activated Carbon for Pharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Activated Carbon for Pharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Activated Carbon for Pharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Activated Carbon for Pharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Activated Carbon for Pharmaceuticals in 2021
Figure 77. Manufacturing Process Analysis of Activated Carbon for Pharmaceuticals
Figure 78. Activated Carbon for Pharmaceuticals Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の活性炭タンク市場2022年：市場規模予測（～2028年）
  • 世界の家庭用活性炭市場2022年：市場規模予測（～2028年）
  • 世界の水処理用活性炭市場2022年：市場規模予測（～2028年）
  • 世界の農業廃棄物由来活性炭市場2022年：市場規模予測（～2028年）
  • 世界の銀含浸ヤシ殻活性炭市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO1755 )"世界の医薬品用活性炭市場2022年：市場規模予測（～2028年）" (英文：Global Activated Carbon for Pharmaceuticals Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。